ABBOTT LABORATORIES (ABT) Net margin 2016–2025
ABBOTT LABORATORIES (ABT) net profit margin by fiscal year — reported net income divided by reported revenue.
14.7%FY2025 · since FY2016: 6.7% → 14.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 14.7% | -17.2 pp |
| FY2024 | 31.9% | +17.7 pp |
| FY2023 | 14.3% | -1.6 pp |
| FY2022 | 15.9% | -0.5 pp |
| FY2021 | 16.4% | +3.4 pp |
| FY2020 | 13.0% | +1.4 pp |
| FY2019 | 11.6% | +3.8 pp |
| FY2018 | 7.7% | +6.0 pp |
| FY2017 | 1.7% | -5.0 pp |
| FY2016 | 6.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice